Skip directly to page options Skip directly to A-Z link
Volume 18, Number 10—October 2012
Letter

Human Parvovirus 4 Viremia in Young Children, Ghana

Jürgen May, Jan Felix Drexler, Ulrike Reber, Nimarko Sarpong, Ohene Adjei, Marcus Panning, Christian Drosten, and Anna Maria Eis-HübingerComments to Author 
Author affiliations: Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany (J. May); University of Bonn Medical Centre, Bonn, Germany (J.F. Drexler, U. Reber, C. Drosten, A.M. Eis-Hübinger); Kwame Nkrumah University of Science and Technology, Kumasi, Ghana (N. Sarpong); Kumasi Centre for Collaborative Research in Tropical Medicine Kumasi (O. Adjei); and Freiburg University Medical Center, Freiburg, Germany (M. Panning)

Main Article

Figure

Parvovirus 4 DNA loads in virus–positive plasma specimens from children compared with those in whole blood samples previously tested (7), Ghana. Virus concentrations are given on a log scale on the y-axis. Each dot represents 1 specimen. Horizontal lines represent median values for each sample group. Children whose plasma was tested had a median age of 15 months, and children whose whole blood was tested had a median age of either 15 or 24 months. Viral load data (i. e., median viral load and ra

Figure. . Parvovirus 4 DNA loads in virus-positive plasma specimens from children compared with those in whole blood samples previously tested (7), Ghana. Virus concentrations are given on a log scale on the y-axis. Each dot represents 1 specimen. Horizontal lines represent median values for each sample group. Children whose plasma was tested had a median age of 15 months, and children whose whole blood was tested had a median age of either 15 or 24 months. Viral load data (i. e., median viral load and range) for the 2 groups of whole blood samples have been reported (7) and were included for comparison with plasma data from this study.

Download

Main Article

References
  1. Simmonds  P, Manning  A, Kenneil  R, Carnie  FW, Bell  JE. Parenteral transmission of the novel human parvovirus PARV4. Emerg Infect Dis. 2007;13:1386–8. DOIPubMedGoogle Scholar
  2. Lahtinen  A, Kivela  P, Hedman  L, Kumar  A, Kantele  A, Lappalainen  M, Serodiagnosis of primary infections with human parvovirus 4, Finland. Emerg Infect Dis. 2011;17:79–82. DOIPubMedGoogle Scholar
  3. Touinssi  M, Brisbarre  N, Picard  C, Frassati  C, Dussol  B, Uch  R, Parvovirus 4 in blood donors, France. Emerg Infect Dis. 2010;16:165–6. DOIPubMedGoogle Scholar
  4. Sharp  CP, Vermeulen  M, Nébié  Y, Djoko  CF, LeBreton  M, Tamoufe  U, Epidemiology of human parvovirus 4 infection in sub-Saharan Africa. Emerg Infect Dis. 2010;16:1605–7. DOIPubMedGoogle Scholar
  5. Benjamin  LA, Lewthwaite  P, Vasanthapuram  R, Zhao  G, Sharp  C, Simmonds  P, Human parvovirus 4 as potential cause of encephalitis in children, India. Emerg Infect Dis. 2011;17:1484–7.PubMedGoogle Scholar
  6. Yu  X, Zhang  J, Hong  L, Wang  J, Yuan  Z, Zhang  X, High prevalence of human parvovirus 4 infection in HBV and HCV infected individuals in Shanghai. PLoS ONE. 2012;7:e29474. DOIPubMedGoogle Scholar
  7. Panning  M, Kobbe  R, Vollbach  S, Drexler  JF, Adjei  S, Adjei  O, Novel human parvovirus 4 genotype 3 in infants, Ghana. Emerg Infect Dis. 2010;16:1143–6. DOIPubMedGoogle Scholar
  8. Fryer  JF, Delwart  E, Hecht  FM, Bernardin  F, Jones  MS, Shah  N, Frequent detection of the parvoviruses, PARV4 and PARV5, in plasma from blood donors and symptomatic individuals. Transfusion. 2007;47:1054–61. DOIPubMedGoogle Scholar
  9. Sharp  CP, Lail  A, Donfield  S, Gomperts  ED, Simmonds  P. Virologic and clinical features of primary infection with human parvovirus 4 in subjects with hemophilia: frequent transmission by virally inactivated clotting factor concentrates. Transfusion. 2012;52:1482–9. DOIPubMedGoogle Scholar
  10. Chen  MY, Yang  SJ, Hung  CC. Placental transmission of human parvovirus 4 in newborns with hydrops, Taiwan. Emerg Infect Dis. 2011;17:1954–6. DOIPubMedGoogle Scholar

Main Article

Page created: September 19, 2012
Page updated: September 19, 2012
Page reviewed: September 19, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external